131 related articles for article (PubMed ID: 36705478)
1. Heritable Defects in Mitotic and Telomere Function Confer Sarcoma Risk.
Cancer Discov; 2023 Mar; 13(3):529. PubMed ID: 36705478
[TBL] [Abstract][Full Text] [Related]
2. Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Randall RL; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; ; Haber M; Marshall G; Cairns MJ; Blay JY; ; Thomas DM; Tattersall M; Neuhaus S; Lewis C; Tucker K; Carey-Smith R; Wood D; Porceddu S; Dickinson I; Thorne H; James P; Ray-Coquard I; Blay JY; Cassier P; Le Cesne A; Duffaud F; Penel N; Isambert N; Kurtz JE; Puri A; Sarin R; Ahn JH; Kim JE; Ward I; Judson I; van der Graaf W; Seddon B; Chandrasekar C; Rickar R; Hennig I; Schiffman J; Randall RL; Silvestri A; Zaratzian A; Tayao M; Walwyn K; Niedermayr E; Mang D; Clark R; Thorpe T; MacDonald J; Riddell K; Mar J; Fennelly V; Wicht A; Zielony B; Galligan E; Glavich G; Stoeckert J; Williams L; Djandjgava L; Buettner I; Osinki C; Stephens S; Rogasik M; Bouclier L; Girodet M; Charreton A; Fayet Y; Crasto S; Sandupatla B; Yoon Y; Je N; Thompson L; Fowler T; Johnson B; Petrikova G; Hambridge T; Hutchins A; Bottero D; Scanlon D; Stokes-Denson J; Génin E; Campion D; Dartigues JF; Deleuze JF; Lambert JC; Redon R; Ludwig T; Grenier-Boley B; Letort S; Lindenbaum P; Meyer V; Quenez O; Dina C; Bellenguez C; Le Clézio CC; Giemza J; Chatel S; Férec C; Le Marec H; Letenneur L; Nicolas G; Rouault K
Science; 2023 Jan; 379(6629):253-260. PubMed ID: 36656928
[TBL] [Abstract][Full Text] [Related]
3. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
4. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
5. [Telomere anomalies, chromosome reshaping and cancer: an explanatory model of the formation of carcinomas].
Larsen CJ
Bull Cancer; 2000 Oct; 87(10):694-5. PubMed ID: 11185524
[No Abstract] [Full Text] [Related]
6. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
7. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma.
Xie H; Wu X; Wang S; Chang D; Pollock RE; Lev D; Gu J
Cancer; 2013 May; 119(10):1885-91. PubMed ID: 23408253
[TBL] [Abstract][Full Text] [Related]
8. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Barthel FP; Wei W; Tang M; Martinez-Ledesma E; Hu X; Amin SB; Akdemir KC; Seth S; Song X; Wang Q; Lichtenberg T; Hu J; Zhang J; Zheng S; Verhaak RG
Nat Genet; 2017 Mar; 49(3):349-357. PubMed ID: 28135248
[TBL] [Abstract][Full Text] [Related]
11. Cell death during crisis is mediated by mitotic telomere deprotection.
Hayashi MT; Cesare AJ; Rivera T; Karlseder J
Nature; 2015 Jun; 522(7557):492-6. PubMed ID: 26108857
[TBL] [Abstract][Full Text] [Related]
12. Correlations of telomere length, P53 mutation, and chromosomal translocation in soft tissue sarcomas.
Liu C; Li B; Li L; Zhang H; Chen Y; Cui X; Hu J; Jiang J; Qi Y; Li F
Int J Clin Exp Pathol; 2015; 8(5):5666-73. PubMed ID: 26191279
[TBL] [Abstract][Full Text] [Related]
13. Replication stress induces mitotic death through parallel pathways regulated by WAPL and telomere deprotection.
Masamsetti VP; Low RRJ; Mak KS; O'Connor A; Riffkin CD; Lamm N; Crabbe L; Karlseder J; Huang DCS; Hayashi MT; Cesare AJ
Nat Commun; 2019 Sep; 10(1):4224. PubMed ID: 31530811
[TBL] [Abstract][Full Text] [Related]
14. Telomere length maintenance--an ALTernative mechanism.
Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
[TBL] [Abstract][Full Text] [Related]
15. Telomere maintenance and the etiology of adult glioma.
Walsh KM; Wiencke JK; Lachance DH; Wiemels JL; Molinaro AM; Eckel-Passow JE; Jenkins RB; Wrensch MR
Neuro Oncol; 2015 Nov; 17(11):1445-52. PubMed ID: 26014050
[TBL] [Abstract][Full Text] [Related]
16. A non-catalytic N-terminus domain of WRN prevents mitotic telomere deprotection.
Romero-Zamora D; Hayashi MT
Sci Rep; 2023 Jan; 13(1):645. PubMed ID: 36635307
[TBL] [Abstract][Full Text] [Related]
17. Hypothesis on transmission of longevity based on telomere length and state of integrity.
Manestar-Blazić T
Med Hypotheses; 2004; 62(5):770-2. PubMed ID: 15082104
[TBL] [Abstract][Full Text] [Related]
18. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers.
Henson JD; Reddel RR
FEBS Lett; 2010 Sep; 584(17):3800-11. PubMed ID: 20542034
[TBL] [Abstract][Full Text] [Related]
19. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
Montgomery E; Argani P; Hicks JL; DeMarzo AM; Meeker AK
Am J Pathol; 2004 May; 164(5):1523-9. PubMed ID: 15111298
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.
Liau JY; Lee JC; Tsai JH; Yang CY; Liu TL; Ke ZL; Hsu HH; Jeng YM
Mod Pathol; 2015 Dec; 28(12):1545-54. PubMed ID: 26428317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]